CA
LABD icon

CHI Advisors’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

CHI Advisors’s Portfolio LABD Stock Details LABD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$4.63M Sell
22,500
-10,000
-31% -$1.62M 1.84% 15
2023
Q2 		$4.67M Buy
+32,500
New +$4.85M 1.42% 14
2023
Q1 		– Sell
-2,500
Closed -$431K – 25
2022
Q4 		$431K Sell
2,500
-2,500
-50% -$512K 0.11% 22
2022
Q3 		$1.2M Buy
+5,000
New +$1.16M 0.32% 25

Other funds holding LABD

VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
HT
Headlands Technologies Chicago, Illinois $878M AUM 44.8% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

CHI Advisors's LABD Position: Q3 2023 in Review

CHI Advisors reduced its Direxion Daily S&P Biotech Bear 3X ETF (LABD) stake by 31% in Q3 2023, selling an estimated $1.62M and leaving 22,500 shares worth $4.63M. The position accounts for 1.84% of the portfolio, ranked #15.

CHI Advisors first reported a position in LABD in Q3 2022 and has held it in 4 quarters since. The position peaked at $4.67M in Q2 2023. 16 funds tracked by Wall St. Rank hold LABD as of Q3 2023.

  • CHI Advisors held 22,500 shares of Direxion Daily S&P Biotech Bear 3X ETF worth $4.63M as of Q3 2023.
  • CHI Advisors sold 10,000 Direxion Daily S&P Biotech Bear 3X ETF shares in Q3 2023, an estimated $1.62M.
  • Direxion Daily S&P Biotech Bear 3X ETF made up 1.84% of CHI Advisors's portfolio in Q3 2023, its #15 holding.
  • CHI Advisors first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q3 2022 and has held it in 4 quarters since.
  • CHI Advisors's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $4.67M in Q2 2023.
  • 16 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q3 2023.

Based on CHI Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.